OLICERIDINE
| Brand name | OLINVYK |
|---|---|
| Active ingredient | OLICERIDINE |
| Strength | 1MG/ML (1MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | October 2020 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 11931350 | March 2032 | substance |
| 9642842 | March 2032 | product |
| 8835488 | March 2032 | substance, product |
| 9309234 | March 2032 | substance, product |
| 11077098 | March 2032 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.